NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

I don’t have a clue why CVM’s share price would impact NWBO. But I do understand why Linda wants a journal article to clear up any confusion about the success of the trial. Just look at your post as an example.

And previously upstream:

Did CVM fail?

The CVM trial failed the primary OS in the trial. From the PR you quoted:

When the complete study population to which the Multikine treatment regimen was administered (i.e., the combined lower risk (no chemotherapy) and higher risk (with chemotherapy added)) was compared to control, the study did not achieve its primary endpoint of a 10% improvement in overall survival.

The line you posted was for a subgroup. That a subgroup had P<.05 means little. Happens often and does not do much good w/o more trials.

There was no mention at all of the full population results other than that they failed.